• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌新辅助化疗后腋窝再分期:阴性影像学发现的残留转移性淋巴结疾病的预测因素。

Restaging the axilla after neo-adjuvant chemotherapy for breast cancer: Predictive factors for residual metastatic lymph node disease with negative imaging findings.

机构信息

Department of Radiology, Kyungpook National University Chilgok Hospital, Daegu, South Korea.

Department of Radiology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, South Korea.

出版信息

Breast J. 2019 Mar;25(2):196-201. doi: 10.1111/tbj.13192. Epub 2019 Feb 3.

DOI:10.1111/tbj.13192
PMID:30714256
Abstract

To evaluate predictive factors for residual metastatic axillary lymph node (ALN) disease in patients with negative imaging findings after neo-adjuvant chemotherapy (NAC) for breast cancer. From January 2011 to December 2015, 206 patients underwent imaging including ultrasonography, MRI, and PET/CT for restaging the axilla after NAC. Data collected included preoperative information regarding histologic grade, hormone receptor (HR) status, and human epidermal growth factor receptor 2 (HER2) status. Multivariate logistic regression analysis was performed to compare patients with and without residual metastatic ALN disease among patients who showed negative imaging findings after NAC. Of the 181 and 25 patients with initially node-positive and node-negative disease, 131 (72.4%) and 23 (92.0%), respectively, showed negative imaging findings after NAC. Among these 131 and 23 patients, 53 (40.5%) and two patients (8.7%), respectively, had residual metastatic ALN disease. Low to moderate tumor grade (odds ratio [OR] = 5.2, P = 0.009), positive HR status (OR = 6.6, P = 0.003), and negative HER2 status (OR = 2.6, P = 0.048) were associated with residual metastatic ALN disease. Low to moderate histologic grade, positive HR status, and negative HER2 status may serve as predictors of residual metastatic ALN disease in patients with negative imaging findings after NAC for breast cancer.

摘要

评估新辅助化疗(NAC)后乳腺癌阴性影像学发现患者残留转移性腋窝淋巴结(ALN)疾病的预测因素。从 2011 年 1 月至 2015 年 12 月,206 例患者接受了包括超声、MRI 和 PET/CT 在内的影像学检查,以对 NAC 后腋窝进行重新分期。收集的术前数据包括组织学分级、激素受体(HR)状态和人表皮生长因子受体 2(HER2)状态。多变量逻辑回归分析用于比较 NAC 后影像学阴性发现的患者中有无残留转移性 ALN 疾病的患者。在最初淋巴结阳性和淋巴结阴性的 181 例和 25 例患者中,131 例(72.4%)和 23 例(92.0%)分别在 NAC 后显示阴性影像学发现。在这 131 例和 23 例患者中,53 例(40.5%)和 2 例患者(8.7%)分别有残留转移性 ALN 疾病。低至中度肿瘤分级(比值比 [OR] = 5.2,P = 0.009)、HR 状态阳性(OR = 6.6,P = 0.003)和 HER2 状态阴性(OR = 2.6,P = 0.048)与残留转移性 ALN 疾病相关。低至中度组织学分级、HR 状态阳性和 HER2 状态阴性可能是 NAC 后乳腺癌阴性影像学发现患者残留转移性 ALN 疾病的预测因素。

相似文献

1
Restaging the axilla after neo-adjuvant chemotherapy for breast cancer: Predictive factors for residual metastatic lymph node disease with negative imaging findings.乳腺癌新辅助化疗后腋窝再分期:阴性影像学发现的残留转移性淋巴结疾病的预测因素。
Breast J. 2019 Mar;25(2):196-201. doi: 10.1111/tbj.13192. Epub 2019 Feb 3.
2
Axillary Pathologic Complete Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer Patients: A Predictive Model Integrating the Imaging Characteristics of Ultrasound Restaging with Known Clinicopathologic Characteristics.临床淋巴结阳性乳腺癌患者新辅助化疗腋窝病理完全缓解:整合超声再分期的影像学特征与已知临床病理特征的预测模型。
Ultrasound Med Biol. 2019 Mar;45(3):702-709. doi: 10.1016/j.ultrasmedbio.2018.10.026. Epub 2018 Dec 17.
3
False negative results in axillary lymph nodes by ultrasonography and ultrasonography-guided fine-needle aspiration in patients with invasive ductal carcinoma.超声及超声引导下细针抽吸对浸润性导管癌腋窝淋巴结假阴性的结果。
Ultraschall Med. 2013 Dec;34(6):559-67. doi: 10.1055/s-0032-1313113. Epub 2012 Dec 20.
4
Neo-adjuvant chemotherapy and axillary de-escalation management for patients with clinically node-negative breast cancer.新辅助化疗和临床淋巴结阴性乳腺癌的腋窝降阶管理。
Breast J. 2019 Nov;25(6):1154-1159. doi: 10.1111/tbj.13422. Epub 2019 Jul 22.
5
Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.新辅助化疗后临床腋窝淋巴结阳性乳腺癌患者中乳腺MRI在腋窝反向映射方面的临床影响
Eur J Surg Oncol. 2016 May;42(5):672-8. doi: 10.1016/j.ejso.2016.02.005. Epub 2016 Feb 10.
6
Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer.乳腺磁共振成像和肿瘤生物学预测乳腺癌新辅助化疗腋窝淋巴结的反应。
Cancer Imaging. 2019 Dec 26;19(1):91. doi: 10.1186/s40644-019-0279-4.
7
Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer.预测新辅助化疗后的腋窝反应:淋巴结阳性乳腺癌患者的乳腺 MRI 和 US。
Radiology. 2019 Oct;293(1):49-57. doi: 10.1148/radiol.2019190014. Epub 2019 Aug 13.
8
Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.新辅助化疗后乳腺 MRI 成像和 PET/CT 对浸润性导管癌患者腋窝淋巴结转移(ypN2-3)的预测。
Sci Rep. 2018 Feb 16;8(1):3181. doi: 10.1038/s41598-018-21554-z.
9
Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.新辅助化疗后细胞学证实淋巴结阳性乳腺癌的前哨淋巴结活检。
Clin Breast Cancer. 2013 Dec;13(6):471-7. doi: 10.1016/j.clbc.2013.08.014.
10
CT-Guided Wire Localization for Involved Axillary Lymph Nodes After Neo-adjuvant Chemotherapy in Patients With Initially Node-Positive Breast Cancer.新辅助化疗后初始淋巴结阳性乳腺癌患者受累腋窝淋巴结的CT引导下金属丝定位
Breast J. 2016 Jul;22(4):390-6. doi: 10.1111/tbj.12597. Epub 2016 Apr 9.

引用本文的文献

1
F-FDG PET/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients.F-FDG PET/CT影像组学分析及人工智能预测乳腺癌患者新辅助化疗后的病理完全缓解
Radiol Med. 2025 Apr;130(4):543-554. doi: 10.1007/s11547-025-01958-4. Epub 2025 Jan 28.
2
Analysis of factors influencing the pathological complete remission (ipCR) in patients with internal mammary lymph node metastasis after neoadjuvant chemotherapy.分析新辅助化疗后内乳淋巴结转移患者病理完全缓解(ypCR)的影响因素。
PeerJ. 2023 Oct 6;11:e16141. doi: 10.7717/peerj.16141. eCollection 2023.
3
Best MRI sequences for identifying axillary lymph node markers in patients with metastatic breast cancer: an inter-reader observational study.
最佳 MRI 序列用于识别转移性乳腺癌患者腋窝淋巴结标志物:一项观察者间的观察性研究。
Eur Radiol Exp. 2020 Jun 12;4(1):34. doi: 10.1186/s41747-020-00161-6.